[HTML][HTML] Gut microbiota: a newly identified environmental factor in systemic lupus erythematosus
K Yao, Y Xie, J Wang, Y Lin, X Chen… - Frontiers in …, 2023 - frontiersin.org
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that predominantly
affects women of childbearing age and is characterized by the damage to multiple target …
affects women of childbearing age and is characterized by the damage to multiple target …
[HTML][HTML] COVID-19 and multiple sclerosis: a complex relationship possibly aggravated by low vitamin D levels
WD Fernandes de Souza, DM Fonseca, A Sartori - Cells, 2023 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an exceptionally
transmissible and pathogenic coronavirus that appeared at the end of 2019 and triggered a …
transmissible and pathogenic coronavirus that appeared at the end of 2019 and triggered a …
[HTML][HTML] Genetic risk score in multiple sclerosis is associated with unique gut microbiome
NS Elsayed, RK Valenzuela, T Kitchner, T Le… - Scientific Reports, 2023 - nature.com
Multiple sclerosis (MS) is a complex autoimmune disease in which both the roles of genetic
susceptibility and environmental/microbial factors have been investigated. More than 200 …
susceptibility and environmental/microbial factors have been investigated. More than 200 …
Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis
D Kujawa, L Laczmanski, S Budrewicz… - Gut …, 2023 - Taylor & Francis
Multiple sclerosis (MS) causes long-lasting, multifocal damage to the central nervous
system. The complex background of MS is associated with autoimmune inflammation and …
system. The complex background of MS is associated with autoimmune inflammation and …
[HTML][HTML] Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis
Since the first model of experimental autoimmune encephalomyelitis (EAE) was introduced
almost a century ago, there has been an ongoing scientific debate about the risks and …
almost a century ago, there has been an ongoing scientific debate about the risks and …
[HTML][HTML] Limosilactobacillus reuteri in immunomodulation: molecular mechanisms and potential applications
Z Luo, A Chen, A Xie, X Liu, S Jiang, R Yu - Frontiers in Immunology, 2023 - frontiersin.org
Frequent use of hormones and drugs may be associated with side-effects. Recent studies
have shown that probiotics have effects on the prevention and treatment of immune-related …
have shown that probiotics have effects on the prevention and treatment of immune-related …
[HTML][HTML] Multiple sclerosis-associated gut microbiome in the israeli diverse populations: associations with ethnicity, gender, disability status, Vitamin D levels, and …
Z Nitzan, E Staun-Ram, A Volkowich… - International Journal of …, 2023 - mdpi.com
Microbiome dysbiosis is increasingly being recognized as implicated in immune-mediated
disorders including multiple sclerosis (MS). The microbiome is modulated by genetic and …
disorders including multiple sclerosis (MS). The microbiome is modulated by genetic and …
[HTML][HTML] Role of fenofibrate in multiple sclerosis
Multiple sclerosis (MS) is the most frequent inflammatory and demyelinating disease of the
central nervous system (CNS). The underlying pathophysiology of MS is the destruction of …
central nervous system (CNS). The underlying pathophysiology of MS is the destruction of …
Probiotics and the microbiota-gut-brain axis in neurodegeneration: Beneficial effects and mechanistic insights
FT Ghassab, FS Mahmoudi, RT Tinjani, AE Meibodi… - Life Sciences, 2024 - Elsevier
Neurodegenerative diseases (NDs) are a group of heterogeneous disorders with a high
socioeconomic burden. Although pharmacotherapy is currently the principal therapeutic …
socioeconomic burden. Although pharmacotherapy is currently the principal therapeutic …
Therapeutic consequences in patients with both inflammatory rheumatic diseases and multiple sclerosis
JG Letarouilly, P Vermersch, RM Flipo - Rheumatology, 2023 - academic.oup.com
Dealing with patients with both multiple sclerosis (MS) and inflammatory rheumatic disorders
(IRDs) is not uncommon for a rheumatologist, as there is a statistical association between …
(IRDs) is not uncommon for a rheumatologist, as there is a statistical association between …